Spero Therapeutics, Inc. (SPRO)
2.79
+0.03
(+1.09%)
USD |
NASDAQ |
May 15, 16:00
2.795
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics EPS Diluted (Quarterly) : -0.1258 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.0487 |
| Lantern Pharma, Inc. | -0.2958 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.203M |
| Revenue (Quarterly) | 0.258M |
| Total Expenses (Quarterly) | 7.461M |
| Enterprise Value | 107.89M |
| Profit Margin (Quarterly) | -2.79K% |
| Earnings Yield | 8.73% |
| Operating Earnings Yield | 4.86% |
| Normalized Earnings Yield | 9.032 |